SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001013594-08-000280
Filing Date
2008-05-01
Accepted
2008-05-01 11:40:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 MAY 1, 2008 enzon13da-050108.htm SC 13D/A 178158
2 GRAPHIC img1.jpg GRAPHIC 8171
  Complete submission text file 0001013594-08-000280.txt   191764
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-35587 | Film No.: 08793192
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 200 PARK AVENUE, SUITE 3300 NEW YORK NY 10166
Business Address 200 PARK AVENUE, SUITE 3300 NEW YORK NY 10166 (212) 808-3590
DellaCamera Capital Management, LLC (Filed by) CIK: 0001391052 (see all company filings)

IRS No.: 061757281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A